Kevin Chau

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Immune Response

Endoplasmic Reticulum Stress

Endometrial Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Neil A O'Brien, Martina S J McDermott, Jun Zhang, Ke Wei Gong, Ming Lu, Benjamin Hoffstrom, Tong Luo, Raul Ayala, Kevin Chau, Min Liang, Athena M Madrid, Timothy R Donahue, John A Glaspy, Leonard Presta, Dennis J Slamon
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-drug Conjugate for Treatment of CLDN18.2 Positive Cancers. Molecular cancer therapeutics (2023)
Martina S J McDermott, Neil A O'Brien, Benjamin Hoffstrom, Ke Wei Gong, Ming Lu, Jun Zhang, Tong Luo, Min Liang, Weiping Jia, Jenny Hong, Kevin Chau, Simon Davenport, Bin Xie, Michael F Press, Richard Panayiotou, Abram Handly-Santana, Joan S Brugge, Leonard Presta, John A Glaspy, Dennis J Slamon
Preclinical Efficacy of the Antibody-Drug-Conjugate CLDN6-23-ADC for the Treatment of CLDN6 Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Razmik Ghukasyan, Keke Liang, Kevin Chau, Luyi Li, Charlotte Chan, Evan R Abt, Thuc Le, Joon Y Park, Nanping Wu, Alykhan M Premji, Robert Damoiseaux, Tony Luu, Amanda Labora, Khalid Rashid, Jason M Link, Caius G Radu, Timothy R Donahue
MEK inhibition sensitizes pancreatic cancer to STING agonism by tumor-cell intrinsic amplification of type I interferon signaling. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)